Drugs / Infanrix™-IPV/Hib
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01003418 Background | Nov 2009 → Nov 2010 | influenza | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV/Hib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01003418 ↗ |
| Modality | Vaccine | “Routine infant immunisation vaccine” NCT01003418 ↗ |
| Route | Intramuscular | “three doses administered intramuscularly” NCT01003418 ↗ |